Evolutionism

Protein Evolution, Inc. and Basecamp Research Aim to Make Polyurethane and Nylon Infinitely Recyclable with Expanded Strategic Collaboration

Retrieved on: 
Wednesday, January 24, 2024

Protein Evolution’s Biopure™ technology uses AI-designed enzymes to currently break down polyester waste and transform it into the building blocks of new polyester.

Key Points: 
  • Protein Evolution’s Biopure™ technology uses AI-designed enzymes to currently break down polyester waste and transform it into the building blocks of new polyester.
  • By leveraging Basecamp Research’s biodiversity mapping system, Protein Evolution will unlock previously inaccessible enzymes to break down polyurethane and polyamide waste.
  • Polyurethane, commonly found in products like spandex, mattresses, sofas, car seats, and insulation panels, poses a substantial recycling challenge.
  • By combining Basecamp Research’s platform with Protein Evolution’s scale-up expertise, this collaboration will accelerate the development timelines of novel enzymes for biological recycling from years to months.

Protein Evolution, Inc. and Fashion Sustainability Pioneer, Stella McCartney, Debut The World’s First Garment Made Using Biological Recycling

Retrieved on: 
Friday, December 1, 2023

“Today marks a pivotal moment in the move towards textile-to-textile circularity in the fashion industry,” said Connor Lynn, Co-Founder and Chief Business Officer of Protein Evolution.

Key Points: 
  • “Today marks a pivotal moment in the move towards textile-to-textile circularity in the fashion industry,” said Connor Lynn, Co-Founder and Chief Business Officer of Protein Evolution.
  • Biopure is capable of handling a variety of waste streams, from plastic bottles and clam-shells, to industrial textiles and garments.
  • “Anybody who knows me knows that I hate waste, which is why I am so thrilled about our collaboration with Protein Evolution,” said Stella McCartney.
  • “It’s remarkable what the company has achieved in less than a year of this collaboration with our partner Stella McCartney.

New Public-Private Partnerships Look to AI and Enzymes to Break Down Plastic and Textile Waste

Retrieved on: 
Tuesday, October 10, 2023

The first project will leverage the team’s collective advancements in artificial intelligence to create enzymes that break down plastic and textile waste, and the second will streamline the methods for manufacturing these enzymes at scale.

Key Points: 
  • The first project will leverage the team’s collective advancements in artificial intelligence to create enzymes that break down plastic and textile waste, and the second will streamline the methods for manufacturing these enzymes at scale.
  • Protein Evolution’s partnerships with JBEI, ABF and ABPDU share the overarching goal to reduce emissions from petroleum-based plastic production and the landfilling and incineration of plastic waste.
  • As one of the ABF’s five newly selected projects aimed to decarbonize society, Protein Evolution will use AI to design new classes of enzymes to break down plastic.
  • “We are hopeful that this partnership will make a major impact on how plastic waste is handled and new plastic material is produced in the future.”

Survey Finds 93% of Americans Overestimate the Amount of Plastic Recycled and Reused Each Year

Retrieved on: 
Tuesday, May 9, 2023

Almost all Americans (93%) overestimate the percentage of plastic products that are recycled and reused each year, including 35% who mistakenly think it is half or more.

Key Points: 
  • Almost all Americans (93%) overestimate the percentage of plastic products that are recycled and reused each year, including 35% who mistakenly think it is half or more.
  • More than 4 in 5 Americans believe they’re at least somewhat knowledgeable about ways to reduce plastic waste in their day-to-day life.
  • Nearly 7 in 10 Americans (69%) do not recognize that crude oil is used to produce new plastic products, including most textiles for clothing.
  • A massive 98% of Americans overestimate the actual amount of discarded textiles that are recycled, including 30% who believe half or more are recycled.

AM Best Assigns Credit Ratings to Stellar National Life Insurance Company

Retrieved on: 
Thursday, January 12, 2023

AM Best has assigned a Financial Strength Rating (FSR) of B++ (Good) and a Long-Term Issuer Credit Rating (Long-Term ICR) of “bbb” (Good) to Stellar National Life Insurance Company (Stellar Life) (Phoenix, AZ).

Key Points: 
  • AM Best has assigned a Financial Strength Rating (FSR) of B++ (Good) and a Long-Term Issuer Credit Rating (Long-Term ICR) of “bbb” (Good) to Stellar National Life Insurance Company (Stellar Life) (Phoenix, AZ).
  • The ratings assigned to Stellar Life reflect AM Best’s expectation that the company will maintain sufficient capital to support its future business plans.
  • Invested assets will be managed by Stellar National IM, LLC (Stellar IM), an affiliate of Stellar Life’s parent company, Stellar National Holdings, LLC (Stellar Holdings).
  • For information on the proper use of Best’s Credit Ratings, Best’s Performance Assessments, Best’s Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Best’s Ratings & Assessments .

Xinhua Silk Road: Cultural fair showcases digital transformation of China's cultural industry

Retrieved on: 
Wednesday, January 4, 2023

In fact, digitalization has become a catalyst for China's cultural industry, and a large number of cultural resources have been revitalized with the empowerment of digital technology.

Key Points: 
  • In fact, digitalization has become a catalyst for China's cultural industry, and a large number of cultural resources have been revitalized with the empowerment of digital technology.
  • For example, Chinese internet giant Tencent and Dunhuang Academy are working together to digitize the cultural relics in the Dunhuang caves.
  • Liu Xiaolan, Tencent's project leader, said that digital technology will move Dunhuang cultural relics online, and people can feel the cultural charm of thousands of years in the digital caves.
  • Besides, virtual reality (VR) technology is playing an increasing role in the digitalization of the cultural industry.

Xinhua Silk Road: Cultural fair showcases digital transformation of China's cultural industry

Retrieved on: 
Wednesday, January 4, 2023

In fact, digitalization has become a catalyst for China's cultural industry, and a large number of cultural resources have been revitalized with the empowerment of digital technology.

Key Points: 
  • In fact, digitalization has become a catalyst for China's cultural industry, and a large number of cultural resources have been revitalized with the empowerment of digital technology.
  • For example, Chinese internet giant Tencent and Dunhuang Academy are working together to digitize the cultural relics in the Dunhuang caves.
  • Liu Xiaolan, Tencent's project leader, said that digital technology will move Dunhuang cultural relics online, and people can feel the cultural charm of thousands of years in the digital caves.
  • Besides, virtual reality (VR) technology is playing an increasing role in the digitalization of the cultural industry.

Protein Evolution, Inc. Unveils New Technology that Infinitely Recycles Textile and Plastic Waste

Retrieved on: 
Monday, October 31, 2022

Today, Protein Evolution , Inc. (PEI) launched out of stealth, unveiling groundbreaking technology that transforms textile and mixed-plastic waste into an infinitely reusable resource, helping the chemicals industry transition to a lower-carbon, circular economy.

Key Points: 
  • Today, Protein Evolution , Inc. (PEI) launched out of stealth, unveiling groundbreaking technology that transforms textile and mixed-plastic waste into an infinitely reusable resource, helping the chemicals industry transition to a lower-carbon, circular economy.
  • Leveraging recent breakthroughs in natural science and artificial intelligence, the company designs enzymes to break down end-of-life textile and plastic waste into the building blocks that make up new textile and plastic products.
  • "Our technology condenses a million-year evolutionary process into a single dayhelping us create an affordable, scalable and effective solution to revolutionize the plastic waste industry."
  • The companys first product is an enzymatic process that enables textile and plastic waste to become an infinitely reusable resource.

Tesseract Health Appoints Dr. Michael McConnell as Head of Cardiovascular and Digital Health

Retrieved on: 
Thursday, April 28, 2022

Tesseract Health , a health technology company developing a portable, non-invasive platform to detect health conditions through the eyes, proudly announces the appointment of Michael McConnell, MD, MSEE, as Tesseracts Head of Cardiovascular and Digital Health.

Key Points: 
  • Tesseract Health , a health technology company developing a portable, non-invasive platform to detect health conditions through the eyes, proudly announces the appointment of Michael McConnell, MD, MSEE, as Tesseracts Head of Cardiovascular and Digital Health.
  • Dr. McConnell was brought on to leverage Tesseracts technology to guide the expansion of its cardiovascular strategy.
  • In this role, he is poised to lead and champion the design, planning, development and clinical research for cardiovascular health products.
  • Im very excited to join Dr. Demas and the Tesseract Health leadership team to advance our mission to democratize point-of-care screening and monitoring of important health conditions, said Dr. McConnell.

AI Therapeutics Announces the Acquisition of Novel Cancer Drug Candidate EC-8042 (AIT-102)

Retrieved on: 
Monday, April 25, 2022

GUILFORD, Conn., April 25, 2022 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc. , an AI driven clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, today announced the acquisition of EntreChem, S.L.s investigational drug candidate EC-8042 (redesignated AIT-102), a novel targeted cancer therapy in development for rare pediatric and other cancers.

Key Points: 
  • GUILFORD, Conn., April 25, 2022 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc. , an AI driven clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, today announced the acquisition of EntreChem, S.L.s investigational drug candidate EC-8042 (redesignated AIT-102), a novel targeted cancer therapy in development for rare pediatric and other cancers.
  • For many tumor types, the biological culprit is well understood, but has proven difficult to target with pharmaceuticals.
  • AIT-102 is a powerful addition to AI Therapeutics rare disease treatment pipeline, said Brigette Roberts, M.D., Chief Executive Officer of AI Therapeutics.
  • AI Therapeutics is part of biotechnology accelerator 4Catalyzer, which has launched Butterfly Network, Quantum-Si, Hyperfine and Liminal Sciences, Detect, Tesseract, and Protein Evolution.